×
About 845 results

ALLMedicine™ Alopecia Areata Center

Research & Reviews  316 results

Prevalence of alopecia areata in Japan: Estimates from a nationally representative sample.
https://doi.org/10.1111/1346-8138.16606
The Journal of Dermatology; Aranishi T, Ito T et. al.

Nov 23rd, 2022 - Data on the prevalence of alopecia areata (AA) in Japan is limited and the epidemiology of the disease there is not well understood; therefore, it is critical to examine the prevalence and severity of AA in Japan to inform the need for future trea...

Emerging drugs for the treatment of alopecia areata.
https://doi.org/10.1080/14728214.2022.2149735
Expert Opinion on Emerging Drugs; Ramírez-Marín HA, Tosti A

Nov 22nd, 2022 - Alopecia Areata (AA) is the second most common non-scarring hair loss disorder, with a prevalence of 1 in 1000 and a lifetime incidence of 2% worldwide. Data from a recent American study shows that from 68,121 patients with the diagnosis of AA, 37...

Prevalence and implications of type D personality in patients with alopecia areata: A m...
https://doi.org/10.1111/jdv.18733
Journal of the European Academy of Dermatology and Venere... Sánchez-Díaz M, Montero-Vílchez T et. al.

Nov 17th, 2022 - Distressed personality (or Type D personality, TDp) is a personality trait that has been associated with poor quality of life in patients suffering from a variety of skin diseases such as psoriasis or urticaria. To date the potential association b...

Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhib...
https://doi.org/10.1016/j.jaut.2022.102926
Journal of Autoimmunity; Paggioli I, Moss J

Nov 7th, 2022 - Alopecia Areata (AA) is a T-cell mediated autoimmune attack on hair follicles resulting in rapidly developing areas of hair loss involving the scalp and beard that can progress to total scalp hair loss (alopecia totalis) and loss of eyebrows, eyel...

Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia ar...
https://doi.org/10.1111/1346-8138.16615
The Journal of Dermatology; Campos-Alberto E, Hirose T et. al.

Nov 3rd, 2022 - Real-world data on alopecia areata (AA) demographics, comorbidities, and treatment patterns are sparse, not only in Japan but worldwide. This cross-sectional study assessed the current prevalence of AA in Japan, including analysis of severe subset...

see more →

News  22 results

Alopecia Areata: Positive Results Reported for Two Investigational JAK Inhibitors
https://www.medscape.com/viewarticle/981622

Sep 29th, 2022 - Treatment with deuruxolitinib and ritlecitinib, two investigational Janus kinase (JAK) inhibitors, resulted in substantial regrowth of scalp hair for patients with alopecia areata (AA) in separate studies reported at the European Academy of Dermat...

Baricitinib's Approval for Alopecia Areata: Considerations for Starting Patients on Treatment
https://www.medscape.com/viewarticle/976527

Jul 1st, 2022 - Dermatologists, who recently celebrated the US Food and Drug Administration's (FDA's) approval of the world's first oral systemic treatment for adults with severe alopecia areata (AA), are now looking ahead to the practicalities of getting the dru...

Baricitinib Recommended for Approval of Severe Alopecia Areata in Europe
https://www.medscape.com/viewarticle/974368

May 20th, 2022 - The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of baricitinib, a Janus kinase (JAK) inhibitor, for the treatment of adults with severe alopecia areata (AA). The development, whi...

Oral Tofacitinib Produces Hair Regrowth in Children With Alopecia Areata
https://www.medscape.com/viewarticle/968410

Feb 14th, 2022 - Oral tofacitinib (Xeljanz), a JAK inhibitor, helped regrow hair in three quarters of pediatric patients with alopecia areata (AA) in a small study conducted at the University of Colorado and published in Pediatric Dermatology. The 11 pediatric pat...

Alopecia Tied to a Threefold Increased Risk for Dementia
https://www.medscape.com/viewarticle/962186

Nov 3rd, 2021 - Alopecia areata (AA), an autoimmune disease that causes hair loss, including baldness, has been linked to a significantly increased risk for dementia, new research shows. After controlling for an array of potential confounders, investigators found...

see more →